USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'middle based system engineering iot bg dpp fleet operator'
- Did you mean
- middle based system engineering iot bg dip fleet operator
- middle based system engineering iot bg dxp fleet operator
- Related search terms
- SYSTEMS AND METHODS FOR AI-ASSISTED SURGERY
- engineering services market automotive research ad development
- iot security market 31 account 2025 growth opportunity
- iot security market 31 auto 2020 growth opportunity
- iot security market 31 auto 2025 growth opportunity
-
24 Apr 2018 | North America | Market Research
Growth Insights—Real World Evidence Analytics Solutions Market
Innovation and Changing End-user Needs Driving Market Growth
Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...
$3,000.00 -
19 Sep 2018 | North America | Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00 -
16 Aug 2016 | North America | Market Research
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...
$7,000.00
